Economic Evaluation of a Bayesian Model to Predict Late-Phase Success of New Chemical Entities
Asher D. Schachter(Visterra (United States)), Stanley N Finkelstein, Gianluca Baio(University College London), Marco Ramoni(Boston Children's Hospital), Thomas G. Roberts(Georgia Institute of Technology)
Cited by 9
Related Papers
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
|The Journal of Experimental Medicine|2003|897
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|567
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
|Journal of Clinical Investigation|2002|236
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
|Journal of Clinical Investigation|2002|204